http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109908362-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_653c418e41edbb4e1ce8bc5e53e70cec
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
filingDate 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a670968971d9e7ec21874b7b14ba4e0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fc9310b4d656b25d8b1c10c822f4fae
publicationDate 2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109908362-A
titleOfInvention A biotin-targeted modified photosensitizer and quercetin nano-drug delivery system
abstract The present disclosure relates to the technical field of nano-drug delivery systems, in particular to a biotin-targeted modified photosensitizer and a quercetin nano-drug delivery system. In view of the poor water solubility and low bioavailability of photochemotherapy agents and quercetin in the prior art, as well as the defects of tumor tolerance brought by photosensitizers. The present disclosure is the first time to use biotin-modified IR780 and quercetin to co-assemble to form a nano-system, which not only solves the shortcomings of quercetin and IR780, such as insoluble in water and low bioavailability, but also overcomes the tumor tolerance caused by photosensitizers. sex. The prepared B780/Qu NPs nano-assemblies, with a particle size of 130 nm, conform to the size range of tumor penetration and retention effects, and have good passive and active targeting.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112933229-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111214656-A
priorityDate 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016011436-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49792009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529444

Total number of triples: 47.